|
FCHSD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.68170000003354E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.298400003653E-08 |
| Normal-vs-Stage2 |
5.537600E-02 |
| Normal-vs-Stage3 |
3.300100E-02 |
| Normal-vs-Stage4 |
1.523630E-02 |
| Stage1-vs-Stage2 |
1.431430E-01 |
| Stage1-vs-Stage3 |
1.081880E-03 |
| Stage1-vs-Stage4 |
3.404200E-02 |
| Stage2-vs-Stage3 |
5.535000E-01 |
| Stage2-vs-Stage4 |
8.321000E-01 |
| Stage3-vs-Stage4 |
5.972000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.3367000000496E-06 |
| Normal-vs-AfricanAmerican |
3.771600E-02 |
| Normal-vs-Asian |
1.921360E-01 |
| Caucasian-vs-AfricanAmerican |
6.942400E-01 |
| Caucasian-vs-Asian |
3.335000E-01 |
| AfricanAmerican-vs-Asian |
3.900800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.20639999999328E-05 |
| Normal-vs-Female |
1.80160999999623E-05 |
| Male-vs-Female |
5.863200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.286620E-01 |
| Normal-vs-Age(41-60Yrs) |
2.07939999996576E-07 |
| Normal-vs-Age(61-80Yrs) |
3.552400E-04 |
| Normal-vs-Age(81-100Yrs) |
4.849800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.389200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.448600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.517000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.299800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.618000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.027400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.22380000472577E-08 |
| Normal-vs-Grade 2 |
1.26570000036352E-08 |
| Normal-vs-Grade 3 |
5.901000E-03 |
| Normal-vs-Grade 4 |
6.042400E-02 |
| Grade 1-vs-Grade 2 |
6.628200E-02 |
| Grade 1-vs-Grade 3 |
2.582300E-04 |
| Grade 1-vs-Grade 4 |
2.016800E-03 |
| Grade 2-vs-Grade 3 |
3.448300E-04 |
| Grade 2-vs-Grade 4 |
1.373910E-02 |
| Grade 3-vs-Grade 4 |
9.244000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.58979965145545E-10 |
| Normal-vs-ccB subtype |
2.876300E-02 |
| ccA subtype-vs-ccB subtype |
8.16900000000231E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.000390E-04 |
| Normal-vs-N1 |
1.614600E-01 |
| N0-vs-N1 |
7.623600E-01 |
|
|
